AUD 0.02
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 18.6 Million | 23.1 Thousand | 2.23 Million | 7.94 Million | 54.72 Thousand | 40.38 Thousand |
Cost of Revenue | 5508.00 | 5825.00 | -25.24 Thousand | -2.14 Million | 5230.00 | 5794.00 |
Gross Profit | 18.59 Million | 17.27 Thousand | 2.25 Million | 10.09 Million | 49.49 Thousand | 34.59 Thousand |
Operating Expenses | 4.62 Million | 3.39 Million | 1.84 Million | 2.42 Million | 2.25 Million | 3.74 Million |
Selling, General and Administrative Expenses | 4.25 Million | 3.39 Million | 1.84 Million | 2.42 Million | 2.25 Million | 3.74 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 362.8 Thousand | -4.57 Million | -13.82 Million | 22.46 Million | -150.44 Thousand | 7294.00 |
Cost and Expenses | 4.62 Million | 3.39 Million | 1.84 Million | 2.43 Million | 2.26 Million | 3.75 Million |
Operating Income | 13.97 Million | -3.39 Million | 381 Thousand | 5.51 Million | -2.26 Million | -3.75 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | -5.00 | -3.00 | -24.89 Thousand | -187.49 Thousand | -1.1 Million |
Earnings before Tax | 13.97 Million | -7.96 Million | -15.67 Million | 20.03 Million | -2.41 Million | -3.71 Million |
Net Income | 13.97 Million | -7.96 Million | -15.67 Million | 20.06 Million | -2.22 Million | -2.6 Million |
Earnings Per Share Basic | 0.02 | -0.01 | -0.04 | 0.05 | -0.01 | -0.01 |
Earnings Per Share Diluted | 0.02 | -0.01 | -0.04 | 0.05 | -0.01 | -0.01 |
Weighted Average Shares Outstanding | 623.18 Million | 577.81 Million | 434.38 Million | 407.96 Million | 310.61 Million | 264.12 Million |
Weighted Average Shares Outstanding (Diluted) | 671.99 Million | 577.81 Million | 434.38 Million | 445.22 Million | 310.61 Million | 264.12 Million |
Gross Margin | 1.00 | 0.75 | 1.01 | 1.27 | 0.90 | 0.86 |
EBIT Margin | 0.77 | -146.79 | 0.17 | 0.69 | -41.28 | -92.81 |
Profit Margin | 0.75 | -344.95 | -7.03 | 2.53 | -40.62 | -64.49 |
EBITDA | 14.34 Million | -7.96 Million | 1.29 Million | 20.04 Million | -2.4 Million | -3.7 Million |
Earnings Before Tax Margin | 0.75 | -147.04 | 0.17 | 0.69 | -41.37 | -92.95 |
Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | 18.6 Million | - | 10.68 Thousand | 23.1 Thousand | 12.42 Thousand | 2.23 Million |
Cost of Revenue | 2883.00 | 2625.00 | 2947.00 | 5825.00 | 2878.00 | -25.24 Thousand |
Gross Profit | 18.59 Million | -2625.00 | 7733.00 | 17.27 Thousand | 9546.00 | 2.25 Million |
Operating Expenses | 14.55 Million | -9.93 Million | 1.41 Million | 3.39 Million | 1.97 Million | 1.84 Million |
Selling, General and Administrative Expenses | 1.99 Million | 2.26 Million | 1.41 Million | - | 1.97 Million | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 12.55 Million | -12.19 Million | - | -4.57 Million | - | -13.82 Million |
Cost and Expenses | 14.55 Million | -9.93 Million | 1.41 Million | 3.39 Million | 1.98 Million | 1.84 Million |
Operating Income | 4.04 Million | 9.93 Million | -1.41 Million | -3.39 Million | -1.98 Million | 381 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 18.6 Million | 5.00 | 3.00 | -5.00 | 2.00 | -3.00 |
Earnings before Tax | 4.04 Million | 9.93 Million | -1.65 Million | -7.96 Million | -6.31 Million | -15.67 Million |
Net Income | 4.04 Million | 9.93 Million | -1.65 Million | -7.96 Million | -6.31 Million | -15.67 Million |
Earnings Per Share Basic | 0.01 | 0.02 | -0.00 | - | -0.01 | - |
Earnings Per Share Diluted | 0.01 | 0.02 | -0.00 | - | -0.01 | - |
Weighted Average Shares Outstanding | 650.62 Million | 621.75 Million | 623.18 Million | 577.81 Million | 526.08 Million | 434.38 Million |
Weighted Average Shares Outstanding (Diluted) | 671.99 Million | 624.9 Million | 623.18 Million | 577.81 Million | 526.08 Million | 434.38 Million |
Gross Margin | 1.00 | - | 0.72 | 0.75 | 0.77 | 1.01 |
EBIT Margin | 0.89 | - | -132.36 | - | -159.19 | - |
Profit Margin | 0.22 | - | -155.11 | -344.95 | -508.13 | -7.03 |
EBITDA | 16.6 Million | -2.26 Million | -1.41 Million | - | -1.97 Million | - |
Earnings Before Tax Margin | 0.22 | - | -132.64 | -147.04 | -159.42 | 0.17 |
AAREYDRUGS
SUGALDAM
SHIVAGR
JUBLPHARMA
EKH
3611